Search results for: NICE
Filter search results
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
…will be implemented, but has indicated that calculations of value will extend beyond the QALY approach currently used by NICE. The Department of Health has stated that it will include…
New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
1 November 2008
…countries, NICE in the UK and IQWiG in Germany. It assesses whether analysts are moving closer to the development of international standards in economic evaluation and what it would take…
Health Economics: An Introduction to Economic Evaluation
3 January 2002
…a section on NICE. The opportunities as well as the problems of using economic evaluations for administrative decisions are similar in other countries, even if the legal and institutional frameworks…
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
1 March 2017
…than 50% of OMPs are routinely funded by the NHS, with one-third of these recommended by NICE. The remaining products are directly procured and made available to patients by NHS…
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
1 February 2021
…27-41% of that used in transport when converted to one common metric, where the health value was based on the £20-30,000 per quality-adjusted life year NICE threshold, and the latter…
Phill O’Neill
22 May 2014
…outputs of NICE, and benchmarking industry performance. Phill was the lead analyst for several industry and Government economic benchmarking initiatives including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market…
Graham Cookson
24 April 2018
…life sciences. He is best known for this work on the economics of staffing and skill mix in the English NHS, which was critical to the development of the NICE…
Simon Brassel
4 March 2019
…an estimate of the global burden of C-19, a description of the Digital Health Landscape in England and an assessment of the impact on NICE’s decisions on international HTA agencies….
Chris Skedgel
15 July 2019
…He has been a Lead Economic Reviewer for the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Common Drug Review (CDR) and has led the development of NICE submissions in…